Page 13 of 25

PA27.7 | Glomerular Manifestations of Systemic Disease — SDL Guide (Part 3)

Interpreting the Clinical Syndrome in Context

A five-panel diagnostic diagram showing how proteinuria level, urine sediment, GFR trajectory, and systemic markers narrow the differential diagnosis of renal disease in systemic illness. — **Panel A:** Diagnostic pathway from known systemic disease to renal signs, urinalysis, renal function tests, systemic markers, and focused differential diagnosis.. **Panel B:** Proteinuria quantification spectrum showing microalbuminuria, subnephrotic proteinuria with haematuria, and nephrotic-range proteinuria with associated diseases.. **Panel C:** Urine sediment microscopy showing RBC casts, granular casts, waxy casts, and large fractured casts with clinical interpretation.. **Panel D:** GFR trajectory graph comparing slowly progressive renal decline over years with rapidly progressive renal failure over weeks.. **Panel E:** Systemic marker matrix correlating diabetic nephropathy, lupus nephritis, amyloidosis, and myeloma kidney with key clinical, serological, and biopsy clues..

When a patient with a known systemic disease develops renal signs, a structured approach to the urinalysis and renal function tests narrows the differential rapidly.

Step 1 — Proteinuria quantification:
• Microalbuminuria (30–300 mg/day ACR): early diabetic nephropathy, stage III Mogensen.
• Nephrotic-range (>3.5 g/day): diabetic nephropathy (advanced), amyloidosis, membranous LN (class V), minimal change lesion in SLE.
• Subnephrotic + haematuria: lupus (classes III/IV), HSP, Goodpasture.

Step 2 — Urine sediment:
• RBC casts → glomerular inflammation (nephritis) → lupus IV, Goodpasture, ANCA vasculitis.
• Granular casts + waxy casts → CKD, diabetic nephropathy (advanced).
• Large fractured casts, giant cell reaction on biopsy → myeloma cast nephropathy.

Step 3 — GFR trajectory:
• Slowly progressive over years → diabetic nephropathy, benign nephrosclerosis, amyloidosis.
• Rapidly progressive (weeks) → malignant hypertension, crescentic GN (Goodpasture, class IV LN with crescents, ANCA).

Step 4 — Correlate with systemic markers:

Systemic Disease	Key Serological / Clinical Clue
Diabetic nephropathy	HbA1c, retinopathy (co-existing microvascular disease), NO biopsy usually needed
Lupus nephritis	ANA, anti-dsDNA, low C3+C4, APLA
Amyloidosis	Serum protein electrophoresis, SAA level, rectal/fat pad biopsy
Myeloma	Serum + urine protein electrophoresis, Bence Jones protein
Goodpasture	Anti-GBM antibody, haemoptysis
Hypertension	BP history, fundoscopy, cardiac LVH
HSP	Palpable purpura, IgA levels

The key rule: proteinuria in a diabetic patient + retinopathy = diabetic nephropathy (no biopsy needed). Atypical features (rapid decline, haematuria, short diabetes duration, NO retinopathy) → biopsy to exclude superimposed non-diabetic renal disease.

CLINICAL PEARL

An important examination and clinical pitfall: not all renal disease in a diabetic is diabetic nephropathy. Studies show 30–40% of diabetic patients biopsied for atypical features have an underlying non-diabetic cause (IgA nephropathy, FSGS, membranous GN, ANCA vasculitis). The biopsy decision hinge-points are: (1) absent diabetic retinopathy (retinopathy almost always precedes nephropathy in type 1 DM; less reliable in type 2), (2) heavy haematuria, (3) rapid GFR decline (>3.5 mL/min/year), (4) short duration of DM (<5 years). In these situations, biopsy changes management in a majority of cases.

SELF-CHECK

A 35-year-old woman with SLE develops rapidly progressive renal failure over 6 weeks. Urinalysis shows 2+ blood with dysmorphic RBCs and RBC casts. Serum C3 and C4 are markedly depressed. Anti-dsDNA titre is very high. Which finding on renal biopsy would MOST specifically indicate that she requires aggressive immunosuppression?

A. Mesangial IgA deposits with mesangial hypercellularity

B. Subepithelial spikes on GBM with diffuse GBM thickening

C. Wire-loop lesions with full-house IF in >50% of glomeruli

D. Acellular mesangial deposits that stain with Congo red

Reveal Answer

Answer: C. Wire-loop lesions with full-house IF in >50% of glomeruli

Wire-loop lesions (massive subendothelial immune complex deposits) with full-house IF (IgG+IgA+IgM+C3+C4+C1q) in >50% of glomeruli defines class IV diffuse lupus nephritis — the most severe class with the worst prognosis and the strongest indication for aggressive immunosuppression (cyclophosphamide/mycophenolate + steroids). Option A describes IgA nephropathy/HSP (not the dominant IF pattern in SLE). Option B describes membranous LN (class V — heavy proteinuria but NOT nephritic/rapidly progressive). Option D describes amyloidosis, not SLE.

Comparing the Major Systemic Glomerulopathies — Summary Table

A comparison diagram shows a normal glomerular filtration barrier above four systemic glomerulopathies: diabetic nephropathy, lupus nephritis IV, lupus nephritis V, and amyloidosis. — **Panel A:** Normal glomerular filtration barrier: capillary lumen, fenestrated endothelium, GBM, podocyte foot processes, mesangium, urinary space. **Panel B:** Diabetic nephropathy: AGEs and haemodynamic injury, Kimmelstiel-Wilson nodules, diffuse mesangial expansion, GBM thickening, linear IgG, late nephrotic syndrome. **Panel C:** Lupus nephritis IV: anti-dsDNA immune complexes, wire-loop lesions, endocapillary proliferation, full-house IF, subendothelial deposits, tubuloreticular inclusions, nephritic plus nephrotic syndrome. **Panel D:** Lupus nephritis V: immune complex injury, GBM spikes and thickening, granular IgG/IgA/IgM staining, subepithelial deposits, nephrotic syndrome. **Panel E:** Amyloidosis: extracellular amyloid deposits, Congo red positivity, apple-green birefringence, randomly arranged fibrils, nephrotic syndrome.

Disease	Primary Mechanism	LM Key Lesion	IF Pattern	EM Key Finding	Dominant Syndrome
Diabetic nephropathy	AGEs, haemodynamic	KW nodules, diffuse mesangial ↑	Non-specific linear IgG	GBM thickening, mesangial ↑	Nephrotic (late)
Lupus nephritis IV	Immune complex (anti-dsDNA)	Wire-loop, endocap proliferation	Full-house	Subendothelial deposits, TRI	Nephrotic + nephritic
Lupus nephritis V	Immune complex	GBM spikes/thickening	IgG, IgA, IgM subepithelial	Subepithelial deposits	Nephrotic
Amyloidosis	Fibril deposition	Amorphous eosinophilic mesangial	Negative (AA); LC-restricted (AL)	8–10 nm non-branching fibrils	Nephrotic
Benign HTN nephrosclerosis	Ischaemia, haemodynamic	Hyaline arteriolosclerosis	Negative	Non-specific	Mild proteinuria, CKD
Malignant HTN nephrosclerosis	Vascular injury	Fibrinoid necrosis, onion-skin	Negative	Fibrin/platelet thrombi	AKI, haematuria
Goodpasture	Anti-GBM Ab	Crescentic GN	Linear IgG along GBM	GBM disruption	Rapidly progressive GN
Amyloid (myeloma-related)	AL protein fibrils	Same as above	Lambda (or kappa) LC	Fibrils	Nephrotic
HSP	IgA vasculitis	Mesangial proliferation	IgA dominant mesangial	Mesangial electron-dense deposits	Haematuria + proteinuria
Cast nephropathy (myeloma)	LC toxicity	Fractured casts, giant cells	Light-chain casts	Non-specific	AKI + myeloma features